Across Markets

Wall Street📈|Alerts🚨|News🗞|🚀 Trade up to $200K funded — zero risk to you.👇

[Across Markets @AcrossMarkets]

Trump Media (DJT) is back on the move with tariff threats, Europe tension & Greenland talk 👀

Chaos or opportunity?

👉 Read the full story & click before everyone else:
https://t.co/RxsFZpRtay
🔁 RT if this surprised you
💬 Comment: BULL or BEAR? $DJT

[Across Markets @AcrossMarkets]

🚨 BIOTECH ALERT 🚨
Pfizer just licensed Novavax’s Matrix-M — yes, that Novavax 👀
Validation play?
New partnerships ahead?
Short-term momentum trade?

👉 Read the full story before the crowd:
https://t.co/LClaFYrfyU
🔁 RT if this surprised you
💬 Comment: BULL or BEAR? $NVAX

[Across Markets @AcrossMarkets]

🚨 FDA SIGNAL 🚨
ImmunityBio’s ANKTIVA gets a no-new-trials resubmission path — shorts are sweating 👀
Biotech catalyst or short squeeze?

👉 Read the breakdown:
https://t.co/447xSEjSVz

🔁 RT | 💬 BULL or BEAR? $IBRX

[Across Markets @AcrossMarkets]

$TTD took a real hit today. VWAP rejected, flush to $39 — that was the market saying “prove it.”
But the bounce back toward $45 shows buyers are still here… just picky.
Full breakdown 🔽
https://t.co/ixVTQ2Btpd

Bull or bear now on $TTD? 👀

[Across Markets @AcrossMarkets]

$SOUN got checked today. Rejected VWAP, momentum cooled — market wants proof, not hype.
But that bounce off $12.50 shows buyers are waiting, not gone.
Full breakdown 🔽
https://t.co/8sJoDPyJUg

[Across Markets @AcrossMarkets]

The Game Gets Serious for $DKNG 🎯
Price action today told the real story — momentum is fading and the market wants proof, not hype. Bulls love the ESPN deal, bears say dilution + competition are catching up. What side are you on? 👀👇
Full breakdown ↓
https://t.co/L1qrcFDYDs

[Across Markets @AcrossMarkets]

$OPEN just had one of those days. Massive volatility, heavy volume, sentiment split right down the middle.
Is this a reset… or the setup before a bigger move? 👀
Full breakdown (no hype, just reality):
https://t.co/xm3S1uAP1f

[Across Markets @AcrossMarkets]

Nancy Pelosi stepping away ends a political era.
A real power vacuum is opening in the Democratic Party.
Who should lead next? 👇
https://t.co/mh3dSc6GTS
#Pelosi

[Across Markets @AcrossMarkets]

$CVNA took a heavy reality check — from the hype highs to a sharp breakdown. 📉
When the chart starts telling the truth, it speaks loud.

Full breakdown + what comes next 👉 https://t.co/Ura6XdBYKH

Do you think this bounce holds or fades again? 👀

[Across Markets @AcrossMarkets]

$CMG broke down hard from the 40s into the low 33s as the market repriced expectations on earnings + same-store sales concerns.

Key support now around 33. Patience > rushing entries.
🔗 https://t.co/r7nUz5Qdmd

[Across Markets @AcrossMarkets]

$MSFT saw a sharp reset today. Strong cloud + AI narrative, but the market is questioning valuation at these levels. Key zones now: 513 support & 539–542 resistance. Patience > chasing.
🔗 https://t.co/MUfeYe0xqI

[Across Markets @AcrossMarkets]

$META took a sharp hit after the recent earnings mood shift. Strong revenue but heavy AI capex + tax charges sparked a fast reset in pricing. Watching key levels around 680–700 now. Cautious patience here makes sense.
🔗 https://t.co/4ToUSqMiwU

[Across Markets @AcrossMarkets]

🚀 $NVDA nears a $5T valuation as AI optimism keeps fueling the rally — but with price stalling near $212 and support around $207, traders are split between hype and caution.
Is this a healthy pause… or a sign of exhaustion? 🤔
👉 Full breakdown: https://t.co/qvXIKFAlg2

[Across Markets @AcrossMarkets]

🚘 $LCID spiked to ~$19.90 then dropped to ~$18.61 fast — momentum fading near VWAP. Partnerships sound bullish, but cash burn & dilution risks linger.
Is this a dip or a warning? 👀
👉 https://t.co/oRZIbMVgG4

[Across Markets @AcrossMarkets]

🚨 $BA showing turbulence again — from ~$223 to ~$214 before rebounding weakly near ~$219. With 777X delays, $53B debt, & a shaky recovery, sellers still have control. Caution first, confidence later. ✈️
Full analysis 👇
🔗 https://t.co/oEcUXVGqb8

[Across Markets @AcrossMarkets]

🚨 $FI (Fiserv, Inc.) just took a brutal hit — dropping from ~$129 to ~$72 in one session.
Guidance slashed, growth outlook reset, and sellers are in full control. ⚠️
Is this a genuine overreaction or the start of deeper trouble? 🤔
Full breakdown 👉 https://t.co/uGLn3jwxuT

[Across Markets @AcrossMarkets]

$DKNG slipped under $32, testing support near $30 after a rough trading day.
Buyers showed up late, but momentum’s weak ahead of earnings. Will bulls step in or is more downside coming?
Full breakdown 👇
🔗 https://t.co/RZ2YCzueZC

[Across Markets @AcrossMarkets]

$PLTR holding firm around $190 after bouncing from $186.78 — strength above VWAP $189.38 shows buyers still in control, but volume hints at caution before earnings. Next move could be key for direction.
Read full analysis 👇
🔗 https://t.co/pqrY0qttnN

[Across Markets @AcrossMarkets]

🚀 $BE surged after-hours to $136 following its $5B partnership with Brookfield to power AI data centers.

Big momentum, but valuation questions linger — can Bloom Energy fuel the next wave of AI growth, or is this run overextended? 👇
🔗 https://t.co/3xzZAUO8YS

[Across Markets @AcrossMarkets]

$AVXL is sitting at a key inflection point as traders await the EMA’s decision on blarcamesine.

A positive nod could spark a major rerating — but failure may sting hard.

How are you positioning ahead of the verdict? 👀
👉 https://t.co/Vw7OLtUC7W